HEMATOLOGIC MALIGNANCIES GRAND ROUNDS 2024 |
06/24/2024 - 4:00pm to 5:00pm EDT |
HEMATOLOGIC MALIGNANCIES GRAND ROUNDS 2024 |
07/08/2024 - 4:00pm to 5:00pm EDT |
Investigating the crosstalk between oncogenic MYC and B-cells in a model of MYC-driven T-cell lymphoma |
08/26/2024 - 4:00pm to 5:00pm EDT |
Leveraging Real-World Evidence to Improve Outcomes in Hematologic Malignancies: The Impact of Biomedical Informatics and AI |
11/18/2024 - 4:00pm to 5:00pm EST |
MM updates from ASCO 2024 |
07/01/2024 - 4:00pm to 5:00pm EDT |
Molecular Clues |
06/17/2024 - 4:00pm to 5:00pm EDT |
MRD+ After Frontline Fixed Duration Venetoclax and Obinutuzumab: What Now? |
05/13/2024 - 4:00pm to 5:00pm EDT |
MyeloMATCH: An NCTN precision medicine initiative for the evaluation of novel therapies in patients with newly diagnosed AML and MDS |
03/11/2024 - 4:00pm to 5:00pm EDT |
Onconephrology: Navigating the Complex Cancer-Kidney Connection |
09/16/2024 - 4:00pm to 5:00pm EDT |
Point-of-care Manufacturing of Cell therapies: Opportunities and Challenges |
05/06/2024 - 4:00pm to 5:00pm EDT |